---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-022969"
form_type: "8-K"
ticker: "CGTX"
cik: "0001455365"
company_name: "COGNITION THERAPEUTICS INC"
filed_at: "2025-03-12T23:59:59+00:00"
generated_at: "2026-05-24T22:14:42.758933+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cognition Therapeutics gets Nasdaq extension to Sept 8, 2025; transfer to Capital Market

## Summary
- Received Nasdaq extension notice on March 12, 2025, granting 180 additional days until Sept 8, 2025 to regain $1.00 minimum bid price.
- Common stock will transfer from Nasdaq Global Market to Nasdaq Capital Market effective March 14, 2025.
- Company will consider options including a reverse stock split to regain compliance.
- If not compliant by Sept 8, 2025, Nasdaq will initiate delisting; company may appeal.
- Bid price has been below $1.00 for over 30 consecutive business days as of Sep 2024.

## SEC filing metadata
- accession: 0001104659-25-022969
- form_type: 8-K
- ticker: CGTX
- cik: 0001455365
- company_name: COGNITION THERAPEUTICS INC
- filed_at: 2025-03-12T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1455365/000110465925022969/0001104659-25-022969-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1455365/000110465925022969/tm258979d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-022969
- JSON: https://secwatch.observer/filing/0001104659-25-022969.json
- Plain text: https://secwatch.observer/filing/0001104659-25-022969.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.